Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.

Publication Type:

Journal Article

Source:

AIDS (London, England), Volume 27, Issue 11, p.1763-70 (2013)

Keywords:

2013, Acquired Immunodeficiency Syndrome, Adenoviruses, Human, Adolescent, Adult, AIDS Vaccines, Caribbean Region, Double-Blind Method, Drug Carriers, Female, Humans, Incidence, July 2014, Middle Aged, North America, Placebos, PREGNANCY, Risk-Taking, Sexual Behavior, South America, Substance-Related Disorders, Vaccine and Infectious Disease Division

Abstract:

Report of risk behavior, HIV incidence, and pregnancy rates among women participating in the STEP study, which is a phase IIB trial of MRKAd5 HIV-1 gag/pol/nef vaccine in HIV-negative individuals who were at high risk of HIV-1.